Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 4
1978 4
1979 8
1980 7
1981 3
1982 1
1983 3
1984 5
1985 5
1986 5
1987 6
1988 6
1989 4
1990 5
1991 2
1992 7
1993 2
1994 9
1995 5
1996 2
1997 5
1998 10
1999 9
2000 11
2001 10
2002 17
2003 22
2004 11
2005 12
2006 14
2007 15
2008 14
2009 14
2010 7
2011 11
2012 8
2013 10
2014 7
2015 6
2016 1
2017 1
2019 2
2020 2
2021 2
2022 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Among authors: jakesz r. N Engl J Med. 2021 Jul 29;385(5):395-405. doi: 10.1056/NEJMoa2104162. N Engl J Med. 2021. PMID: 34320285 Clinical Trial.
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Gnant M, et al. Among authors: jakesz r. Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31. Lancet. 2015. PMID: 26040499 Clinical Trial.
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer.
Gnant M, Frantal S, Pfeiler G, Steger GG, Egle D, Greil R, Fitzal F, Wette V, Balic M, Haslbauer F, Melbinger-Zeinitzer E, Bjelic-Radisic V, Artner-Matuschek S, Kainberger F, Ritter M, Rinnerthaler G, Sevelda P, Bergh J, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Gampenrieder SP, Fohler H, Jakesz R, Fesl C, Singer C. Gnant M, et al. Among authors: jakesz r. NEJM Evid. 2022 Dec;1(12):EVIDoa2200162. doi: 10.1056/EVIDoa2200162. Epub 2022 Nov 18. NEJM Evid. 2022. PMID: 38319865 Clinical Trial.
[Treatment of achalasia].
Cosentini EP, Wenzl E, Jakesz R. Cosentini EP, et al. Among authors: jakesz r. Wien Klin Wochenschr. 2004 May 31;116(9-10):296-304. doi: 10.1007/BF03040899. Wien Klin Wochenschr. 2004. PMID: 15237654 Review. German.
Adjuvant Bisphosphonates and Breast Cancer Survival.
Strobl S, Korkmaz B, Devyatko Y, Schuetz M, Exner R, Dubsky PC, Jakesz R, Gnant M. Strobl S, et al. Among authors: jakesz r. Annu Rev Med. 2016;67:1-10. doi: 10.1146/annurev-med-053014-103600. Epub 2015 Aug 28. Annu Rev Med. 2016. PMID: 26332000 Review.
An update on ovarian suppression/ablation.
Jakesz R. Jakesz R. Int J Gynecol Cancer. 2006;16 Suppl 2:511-4. doi: 10.1111/j.1525-1438.2006.00683.x. Int J Gynecol Cancer. 2006. PMID: 17010060 Review.
Fine-tuning the truth.
Elder EE, Jakesz R. Elder EE, et al. Among authors: jakesz r. World J Surg. 2011 Oct;35(10):2185-6. doi: 10.1007/s00268-011-1233-1. World J Surg. 2011. PMID: 21850600 No abstract available.
298 results